The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mcbride John S. since 2015.
The trader's CIK number is 1618251.
At the time of the last reporting, Mcbride John S. was the Chief Operating Officer of Novus Therapeutics, Inc.. (stock ticker symbol NVUS).
Also see all insider trading activities at Novus Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | TKAI | 0 | $0 | 22,500 | $315,235 | 22,500 | $94,275 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-09-21 | TKAI | Sale | 13,500 | 14.01 | 189,135 |
| 2015-09-21 | TKAI | Option Ex | 13,500 | 4.19 | 56,565 |
| 2015-06-24 | TKAI | Sale | 300 | 14.20 | 4,260 |
| 2015-06-23 | TKAI | Sale | 6,700 | 14.00 | 93,800 |
| 2015-06-24 | TKAI | Option Ex | 300 | 4.19 | 1,257 |
| 2015-06-22 | TKAI | Sale | 2,000 | 14.02 | 28,040 |
| 2015-06-23 | TKAI | Option Ex | 6,700 | 4.19 | 28,073 |
| 2015-06-22 | TKAI | Option Ex | 2,000 | 4.19 | 8,380 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcbride John S. (Chief Operating Officer of Novus Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.